Novartis, a global leader in innovative medicines, has signed a partnership agreement with the Kuwait Society of Dermatologists, focused on transforming dermatological care in Kuwait.
This strategic partnership will prioritize high-impact immunological skin conditions such as Psoriasis, Hidradenitis Suppurativa (HS), and Chronic Spontaneous Urticaria (CSU) with a shared goal of bridging diagnostic gaps and improving the quality of life for patients.
Together, Psoriasis, Hidradenitis Suppurativa (HS), and Chronic Spontaneous Urticaria (CSU) represent distinct chronic inflammatory skin diseases, each with unique clinical presentations and significant impact on quality of life.
Beyond physical symptoms, conditions like Psoriasis, Hidradenitis Suppurativa, and CSU often take a significant toll on patients’ mental health, contributing to anxiety, depression, and social isolation, underscoring the importance of timely, compassionate, and comprehensive care.
This partnership is focused on increasing education and disease awareness within the public and HCPs, in addition to evidence-driven solutions that ensure faster, more accurate diagnoses and better treatment outcomes.
Officials share insights on Novartis-Kuwait Society of Dermatologists partnership
Dr. Atlal Allafi, President of the Kuwait Society of Dermatologists, said that, “Our partnership with Novartis is focused on breaking down barriers to care. Together, we’re working to empower patients to recognize symptoms earlier and support physicians in identifying these conditions sooner. By accelerating diagnosis and access to treatment, we aim to enhance patient outcomes and overall well-being.”
“Driven by our mission to transform the future of medicine, Novartis is proud to join forces with the Kuwait Society of Dermatologists to elevate dermatological care across Kuwait. Through this collaboration, we’re fostering a healthcare environment where early intervention and personalized treatment pave the way for improved patient outcomes,” noted Rabab Monir, Country Operations Head – Kuwait, Novartis.
Dr. Abeer Albazali, Vice President at Kuwait Society of Dermatologists, commented that, “We aim to foster collaboration among dermatologists, encouraging the exchange of knowledge and best practices that drive progress in patient care. This partnership empowers us to move from dialogue to delivery—bringing global breakthroughs to life through locally tailored solutions.”
